Gene: FAM216A
Official Full Name: family with sequence similarity 216 member Aprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00451 | FAM216A gRNA3-gRNA4 KO plasmid | FAM216A | $850 | |||
KO00379 | FAM216A Knockout cell line (Huh-7) | Human | FAM216A | 1:2~1:3 | Negative | Online Inquiry |
KO00739 | FAM216A Knockout cell line (Hep G2) | Human | FAM216A | 1:2~1:4 | Negative | Online Inquiry |
KO17751 | FAM216A Knockout cell line (HeLa) | Human | FAM216A | 1:3~1:6 | Negative | Online Inquiry |
KO17752 | FAM216A Knockout cell line (HCT 116) | Human | FAM216A | 1:2~1:4 | Negative | Online Inquiry |
KO17753 | FAM216A Knockout cell line (HEK293) | Human | FAM216A | 1:3~1:6 | Negative | Online Inquiry |
KO17754 | FAM216A Knockout cell line (A549) | Human | FAM216A | 1:3~1:4 | Negative | Online Inquiry |
FAM216A Gene Knockout Cell Lines are genetically modified cellular systems designed to facilitate the functional analysis of the FAM216A gene, which has been implicated in various biological processes, including cellular signaling, proliferation, and apoptosis. These knockout cell lines are derived using advanced CRISPR-Cas9 technology, ensuring precise removal of the FAM216A gene, creating a platform to study its specific contributions to cellular physiology.
The primary function of FAM216A Gene Knockout Cell Lines is to elucidate the role of FAM216A in cellular mechanisms. Researchers can use these cell lines to investigate how the absence of FAM216A affects cell behavior, signaling pathways, and cellular responses to stimuli. This understanding is pivotal for revealing novel targets for therapeutic interventions in conditions such as cancer or neurodegenerative diseases, where FAM216A may play a critical role.
The scientific importance of these cell lines is underscored by their application in both research and clinical settings. They provide a robust model for studying gene function and the molecular pathways associated with FAM216A, facilitating hypothesis-driven research and providing insights that can translate to clinical applications. The ability to manipulate these cell lines makes them invaluable for drug discovery and development, allowing for targeted testing of pharmacological compounds.
What sets FAM216A Gene Knockout Cell Lines apart from alternatives is their rigorous validation and characterization, ensuring reproducibility and reliability for experimental outcomes. Furthermore, the use of CRISPR-Cas9 technology allows for the creation of specific, clean knockouts that minimize off-target effects, giving researchers confidence in the findings derived from these models.
For researchers and clinicians, the ability to dissect the functional roles of genes like FAM216A in a controlled environment significantly advances our understanding of gene function and potential treatments. By incorporating these knockout cell lines into their studies, users are equipped with potent tools to drive innovation in biological research.
At [Your Company Name], we pride ourselves on our expertise in providing high-quality biological products. Our commitment to scientific excellence ensures that our FAM216A Gene Knockout Cell Lines are not only cutting-edge but also tailored to meet the diverse needs of our clients in advancing their research goals.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.